Spots Global Cancer Trial Database for rabeprazole 40 mg once daily (od)
Every month we try and update this database with for rabeprazole 40 mg once daily (od) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors | NCT01954043 | Cancer | Dabrafenib 150 ... Rabeprazole 40 ... Rifampin 600 mg... | 18 Years - | GlaxoSmithKline | |
A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors | NCT01954043 | Cancer | Dabrafenib 150 ... Rabeprazole 40 ... Rifampin 600 mg... | 18 Years - | GlaxoSmithKline |